NTx, a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the appointment of Dr. Jeff Coller, Bloomberg Distinguished Professor of RNA Biology and Therapeutics at Johns Hopkins University, to its Scientific Advisory Board (SAB).

Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a biotechnology company developing CRISPR-based therapies to cure serious latent viral infectious diseases, today announced that positive preclinical data from its Hepatitis B virus (HBV) EBT-107 program were presented at the 6th ICE-HBV “HBV Cure Symposium” which took place on September 12, 2025, in Berlin, Germany.

Azumo, Inc., the leading developer of reflective display lightguide technologies, and Cymmetrik Group, a leading global provider of printing applications and value-added services, today announced a comprehensive strategic partnership that will redefine manufacturing for next-generation display and lighting applications across Industrial, Automotive, and Consumer Electronics markets.

Intelligent power management company Eaton is collaborating with Xendee Corporation, a provider of the leading design and operation platform for distributed energy and microgrid systems. Xendee’s cutting-edge microgrid modeling and operations platform combined with Eaton’s engineering expertise and proven power distribution technologies deliver a fully integrated microgrid solution. Eaton led a Series B financing round for Xendee Corporation to further accelerate the deployment of artificial intelligence (AI) powered tools for distributed energy resources (DERs), and to help power the next phase of Xendee’s growth. Together, the companies will provide customers a streamlined path to design, deploy and operate highly efficient, resilient microgrids and DERs.

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments, including intubated patients with mechanical ventilation.

Frost & Sullivan is pleased to announce that EnCharge AI has been awarded the 2025 Global Technology Trailblazer Recognition in the advanced analog AI chips sector for its outstanding achievements in innovation, strategy execution, and market disruption. This recognition acknowledges EnCharge AI’s leadership in delivering next-generation compute solutions and redefining AI deployment with transformative performance at the edge.